TheraRadar
← Back
Data updated: Mar 29, 2026

AVENT

NeurologyOncologyMetabolic
Pharma

AVENT is a pharmaceutical company focused on Neurology, Oncology, Metabolic.

1997
Since
2
Drugs
-
Trials
0
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

No recent activity
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 75%
0 drugs Phase 2: 6
Oncology 13%
0 drugs Phase 1: 2
Metabolic 13%
0 drugs Phase 2: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Eli Lilly big-pharma
Metabolic, Oncology, Neurology
Takeda big-pharma
Oncology, Neurology, Metabolic
Novo Nordisk big-pharma
Metabolic, Oncology, Neurology
Amgen biotech
Oncology, Metabolic, Neurology
EMD SERONO INC biotech
Oncology, Neurology, Metabolic